Navigation Links
Gardasil Refused Subsidy

Cervical cancer vaccine, a world-first vaccine which has been shown to prevent 70 per cent of cervical cancers has been removed //from the national immunisation program, according to reports from Labor today.

The government's pharmaceutical advisory body has rejected an application today from Australian manufacturer CSL to make the vaccine Gardasil freely available to all females between ages 12 and 26.

Gardasil, the vaccine designed in Australia halts the spread of sexually-transmitted human papilloma virus (HPV), which causes 70 per cent of cervical cancer.

The NSW Cancer Council has estimated that around 700 Australian women are diagnosed with cervical cancer each year causing about 270 deaths.

Although the vaccine has been on the market for two months it costs $460 for patients to take the recommended three doses.

Only last week the Pharmaceutical Benefits Advisory Committee (PBAC) considered a subsidy for the drug at its regular meeting in Canberra.

CSL and Professor Ian Frazer, who was named Australian of the Year 2006 for designing the vaccine, have been informed today it had been knocked back due to its high price.


NLA
'"/>




Page: 1

Related medicine news :

1. Gardasil vaccine for cervical cancer
2. Gardasil- Cervical Cancer Vaccine Now Approved
3. Gardasil, a cervical cancer vaccine, hits the market
4. Gardasil Hailed as one of the Biggest Research Successes
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. School Vaccination Program to Include Cancer Drug Gardasil
7. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
8. Gardasil – Cervical Cancer Vaccine in UA
9. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
10. Smoker Refused Treatment
11. Boy Refused Compensation For HIV Infection Following Hospital Admission
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...
Breaking Medicine Technology: